| Dr Clarence L Wiley Sr, MD,MMS,FAAD | |
|
1211 N Shartel Ave Ste 407, Oklahoma City, OK 73103-2425 | |
| (405) 278-7911 | |
| (405) 278-7925 |
| Full Name | Dr Clarence L Wiley Sr |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 47 Years |
| Location | 1211 N Shartel Ave Ste 407, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477564797 | NPI | - | NPPES |
| 243432400 | Other | OK | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 12980 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Absentee Shawnee Tribal Health Authority, Inc | 5799171088 | 61 |
News Archive
Independent federal investigators hoping to rein in Medicare fraud are asking Congress for broad new authority to boot offending corporate executives from the insurance program. The change is designed to control Medicare claims fraud by punishing culpable owners, managers and other corporate higher-ups, and not just the convicted companies.
Now, a team of researchers at the University of Maryland presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 in the atmosphere at any location.
Medicaid expansion through the Affordable Care Act has insured millions of low-income people in the United States, improving outcomes for patients with many different diseases.
Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France. The risk factors of breast cancer are varied. They include genetic mutations, late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
› Verified 6 days ago
| Entity Name | Li-si-wi-nwi Health, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124152962 PECOS PAC ID: 4183895519 Enrollment ID: O20130227000474 |
News Archive
Independent federal investigators hoping to rein in Medicare fraud are asking Congress for broad new authority to boot offending corporate executives from the insurance program. The change is designed to control Medicare claims fraud by punishing culpable owners, managers and other corporate higher-ups, and not just the convicted companies.
Now, a team of researchers at the University of Maryland presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 in the atmosphere at any location.
Medicaid expansion through the Affordable Care Act has insured millions of low-income people in the United States, improving outcomes for patients with many different diseases.
Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France. The risk factors of breast cancer are varied. They include genetic mutations, late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
› Verified 6 days ago
| Entity Name | Absentee Shawnee Tribal Health Authority, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942253521 PECOS PAC ID: 5799171088 Enrollment ID: O20220414000294 |
News Archive
Independent federal investigators hoping to rein in Medicare fraud are asking Congress for broad new authority to boot offending corporate executives from the insurance program. The change is designed to control Medicare claims fraud by punishing culpable owners, managers and other corporate higher-ups, and not just the convicted companies.
Now, a team of researchers at the University of Maryland presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 in the atmosphere at any location.
Medicaid expansion through the Affordable Care Act has insured millions of low-income people in the United States, improving outcomes for patients with many different diseases.
Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France. The risk factors of breast cancer are varied. They include genetic mutations, late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clarence L Wiley Sr, MD,MMS,FAAD Po Box 2074, Lowell, AR 72745-2074 Ph: (405) 278-7911 | Dr Clarence L Wiley Sr, MD,MMS,FAAD 1211 N Shartel Ave Ste 407, Oklahoma City, OK 73103-2425 Ph: (405) 278-7911 |
News Archive
Independent federal investigators hoping to rein in Medicare fraud are asking Congress for broad new authority to boot offending corporate executives from the insurance program. The change is designed to control Medicare claims fraud by punishing culpable owners, managers and other corporate higher-ups, and not just the convicted companies.
Now, a team of researchers at the University of Maryland presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 in the atmosphere at any location.
Medicaid expansion through the Affordable Care Act has insured millions of low-income people in the United States, improving outcomes for patients with many different diseases.
Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France. The risk factors of breast cancer are varied. They include genetic mutations, late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
› Verified 6 days ago
Jason Matthew Hirshburg, M.D. PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: University Of Oklahoma Hsc - Dermatology, 619 N.e. 13th St, Oklahoma City, OK 73104 Phone: 405-271-4662 Fax: 405-271-4662 | |
Raymond L Cornelison, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3727 Nw 63rd St Ste 205, Oklahoma City, OK 73116 Phone: 405-608-4494 Fax: 405-608-4504 | |
Dr. Carlos Andres Garcia, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4805 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-1506 Fax: 405-636-1511 | |
Mark Stover Sullivan, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3366 Nw Expressway, Suite 720, Oklahoma City, OK 73112 Phone: 405-947-0676 Fax: 405-945-4876 | |
Dr. Brandon Rhinehart, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western, Ste 301, Oklahoma City, OK 73114 Phone: 405-947-6647 Fax: 405-948-6647 | |
Mark A Dawkins, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13174 N Macarthur Blvd, Oklahoma City, OK 73142 Phone: 405-721-5555 Fax: 405-470-7093 | |
James W Taira, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1211 N Shartel Ave, Suite 202, Oklahoma City, OK 73103 Phone: 405-235-7546 |